Skip to search formSkip to main contentSkip to account menu

clocoumarol

Known as: 3-(1-(4-(2-chloroethyl)phenyl)butyl)-4-hydroxy-2H-1-benzopyran-2-one, 3-(1-(p-chloroethylphenyl)butyl)-4-hydroxycoumarin 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

4-HydroxycoumarinsAnticoagulants

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1987
1987
The thrombopenic effect of ellagic acid in the rat. Another model of platelet stimulation "in vivo".
1987
1987
Mechanism of the congestion of lymph nodes induced by ellagic acid in rats
Intravenous injection of ellagic acid (EA, 30 mg/Kg), an activator of the Hageman factor, induced congestion of lymph nodes and… 
1979
1979
In vitro metabolism of clocoumarol, a new 4-hydroxycoumarin anticoagulant; identification of two additional metabolites.
1978
1978
[Stability of anticoagulant derivatives of 4-hydroxycoumarin. II. Structure of the principal degradation products of phenprocoumin, Clocoumarol, warfarin and acenocoumarin].
1977
1977
In vitro metabolism of a new 4-hydroxycoumarin anticoagulant. Structure of an unusual metabolite.
The metabolism of clocoumarol, 3-[1-[P-(2-chlorethyl)phenyl]butyl]-4-hydroxycoumarin, by rat liver microsomes was investigated… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)